Ads by Google
Disease and Condition
People taking a widely used group of drugs known as calcium channel blockers to treat high blood pressure also appear to be cutting their risk of Parkinson's disease.
A compound that naturally occurs in grapefruit and other citrus fruits may be able to block the secretion of hepatitis C virus from infected cells.
Study has identified insulin resistance in the liver as a key factor in the cause of metabolic syndrome and its associated atherosclerosis.
California Assembly to approve legislation that would require the state Department of Health Care Services to set up the Hepatitis B Prevention and Management Pilot Program Fund.
A new study has identified insulin resistance in the liver as a key factor in the cause of metabolic syndrome.
Researchers discover the origin of hereditary hemochromatosis, a common iron overload disorder, is a genetic defect in the liver.
Two novel proteins studied by a University at Buffalo professor of microbiology and immunology appear to have the potential to enhance the production of antibodies against a multitude of infectious agents.
Novel drug romiplostim significantly improved platelet levels in patients with chronic immune thrombocytopenic purpura - blood disorder.
Two clinical trials of the novel drug romiplostim (Nplate) show that it significantly improved platelet levels in patients with chronic immune thrombocytopenic purpura (ITP), a hematologic disorder that can cause uncontrolled bleeding. An international research team reports Phase 3 trial results for the drug, which duplicates the action of a natural hormone discovered by a Massachusetts General Hospital (MGH) investigator, in the February 2 issue of The Lancet.
A compound that naturally occurs in grapefruit and other citrus fruits may be able to block the secretion of hepatitis C virus (HCV) from infected cells, a process required to maintain chronic infection.
The disease familial combined hyperlipidemia (FCH) is a common cause of disturbed metabolism of fat and early heart attacks.
Hoping to piece together the intricate series of interactions that lead to Huntington's disease, Indiana University Bloomington scientists have determined the shape and structure of a binding site that may prove useful in combating the neurodegenerative disease.
Cytopia'ts lead JAK2 inhibitor compound CYT387 has demonstrated potent activity in cells isolated from patients with myeloproliferative disorders (MPDs).
Two new clinical reports shed light on why some people suffer from recurrent episodes of idiopathic anaphylaxis.
Regenerative Sciences announced a new clinical study using its patent pending processes to treat tendon injuries.
A clinical trial has found that a candidate malaria vaccine was safe and elicited strong immune responses in the 40 Malian adults who received it.
RNA interference (RNAi) represents an innovative new strategy for using small RNA molecules to silence specific genes associated with disease processes.
- « first
- ‹ previous
- next ›
- last »